BEDFORD, Mass.--(BUSINESS WIRE)--May 6, 2019--
Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic
and regenerative medicines company specializing in therapeutics based on
its proprietary hyaluronic
acid ("HA") technology, today announced that the Company
will participate in the following two investor events in May:
- Deutsche Bank 44th Annual Health Care Conference onTuesday, May 7, 2019 at The InterContinental Hotel in Boston.
Singular Research Spring Select Web Call on Thursday, May 30, 2019.
A live audio webcast of the Singular Research Spring Select Web Call may
be accessed via the "Investor
section of Anika’s website at www.anikatherapeutics.com.
An audio archive of the presentation also will be available on the
About Anika Therapeutics, Inc.
Therapeutics, Inc. (NASDAQ: ANIK) is a global, integrated
orthopedic and regenerative medicines company based in Bedford,
Massachusetts. Anika is committed to improving the lives of patients
with degenerative orthopedic diseases and traumatic conditions with
clinically meaningful therapies along the continuum of care, from
palliative pain management to regenerative tissue repair. The Company
has over two decades of global expertise developing, manufacturing, and
commercializing more than 20 products based on its proprietary hyaluronic
acid (HA) technology. Anika's orthopedic medicine portfolio
includes ORTHOVISC®, MONOVISC®,
which alleviate pain and restore joint function by replenishing depleted
HA, and HYALOFAST,
a solid HA-based scaffold to aid cartilage repair and regeneration. For
more information about Anika, please visit www.anikatherapeutics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190506005365/en/
Source: Anika Therapeutics, Inc.
For Investor Inquiries:
Anika Therapeutics, Inc.
Chief Financial Officer
Sonal Vasudev, 917-523-1418